FG
Gaspar, Frédéric
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling | Clinical pharmacokinetics |  | 2025 | 56 | 63 | ||
| The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients : A Physiologically Based Pharmacokinetic Modeling Study | Clinical pharmacology & therapeutics | | 2025 | 64 | 204 | ||
| Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban | British journal of clinical pharmacology |  | 2025 | 66 | 0 | ||
| Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side | CPT: pharmacometrics & systems pharmacology | | 2023 | 142 | 264 | ||
| Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study | CPT: pharmacometrics & systems pharmacology | | 2023 | 132 | 262 | ||
| Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation | Clinical pharmacology and therapeutics | | 2022 | 162 | 227 | ||
| Computer-based strategies to improve safety and riskmanagement of antithrombotic therapies in hospitalizedpatients | | 2022 | 83 | 0 | |||
| Drug-drug interactions with direct oral anticoagulants: practical recommendations for clinicians | The American journal of medicine | | 2021 | 174 | 0 |
